Head Start项目中母亲抑郁预防策略的随机临床试验疗效
这项随机临床试验在6个Head Start机构纳入230名有抑郁情绪、快感缺失或抑郁史但当前无重性抑郁发作的母亲,比较问题解决教育(PSE)与常规服务。意向性分析(223人)显示PSE组抑郁症状加重次数显著少于常规组(aIRR 0.60, 95%CI 0.41-0.90),且在基线症状较低者中预防效果更明显(aIRR 0.39, 95%CI 0.21-0.75),但基线症状较高者无差异。
要点
- PSE可减少低收入母亲抑郁症状加重次数,尤其对基线症状较轻者效果显著。
- 对基线症状较重者,PSE与常规服务无显著差异。
- PSE未改善问题解决技能,但抑郁症状评分变化模式与加重次数一致。
核心结论
- 问题解决教育(PSE)能有效预防抑郁症状发作,且在基线症状较低的母亲中效果最佳。
研究设计与样本
- 随机临床试验于2011年2月15日至2016年5月9日在6个Head Start机构开展,纳入230名有抑郁情绪、快感缺失或抑郁史但当前无重性抑郁发作的母亲。
- 参与者随机接受PSE(n=111)或常规Head Start服务(n=119),随访12个月,采用盲法结局评估。
主要发现
- 意向性分析纳入223名有随访数据的参与者,PSE组与常规组问题解决技能无差异。
- PSE组抑郁症状加重次数均值(SD)为0.84(1.39),常规组为1.12(1.47),调整后发生率比(aIRR)0.60(95%CI 0.41-0.90)。
- 基线症状较低者中,PSE组加重次数均值(SD)0.39(0.84),常规组0.88(1.37),aIRR 0.39(95%CI 0.21-0.75)。
- 基线症状较高者中,PSE组加重次数均值(SD)2.06(1.92),常规组2.00(1.91),aIRR 1.10(95%CI 0.67-1.80)。
- 症状评分分析呈相同模式,基线症状较低者调整后平均降低1.33(95%CI 0.36-2.29)。
临床怎么用
- 在Head Start等社区机构中可嵌入PSE作为抑郁预防策略,优先针对基线症状较轻的母亲。
- 对基线症状较重的母亲,PSE预防效果有限,需考虑其他干预或治疗路径。
局限性
- 研究仅纳入Head Start机构中符合特定抑郁标准母亲,外推需谨慎。
- 需进一步开展Head Start中的有效性研究以制定有意义的公共卫生项目。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Low-income and minority mothers experience a disproportionate incidence of depression and lack access to treatment services. Development of prevention strategies in accessible community-based venues is a potentially important public health strategy. OBJECTIVE: To determine the efficacy of a depression prevention strategy embedded in Head Start. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was performed from February 15, 2011, through May 9, 2016, at 6 Head Start agencies serving families at or below the federal poverty level. Participants included mothers with depressed mood, anhedonia, or depression history but who were not in a current major depressive episode. Participants were followed up for 12 months with masked outcome assessments. Final follow-up was completed on May 9, 2016. INTERVENTIONS: Participants were randomized to a problem-solving education (PSE) intervention (n = 111) or usual Head Start services (n = 119). MAIN OUTCOMES AND MEASURES: Primary outcomes were problem-solving skills and depressive symptoms. To capture the chronicity and intensity of symptoms, the Quick Inventory of Depressive Symptoms was administered bimonthly, and rates of clinically significant symptom elevations were compared across groups. Secondarily, the presence of a major depressive episode was assessed using the Structured Clinical Interview for DSM-IV Axis I Disorders. RESULTS: Among the 230 participants, 152 (66.1%) were Hispanic, with a mean (SD) age of 31.4 (7.3) years. An intention-to-treat analysis among 223 participants contributing follow-up data found no differences in problem-solving skills across groups. The mean (SD) number of depressive symptom elevations among the PSE participants was 0.84 (1.39) compared with 1.12 (1.47) among the usual service participants (adjusted incident rate ratio [aIRR], 0.60; 95% CI, 0.41-0.90). In analyses stratified according to baseline depressive symptoms, PSE exerted a preventive effect among those with lower-level baseline symptoms, with a mean (SD) of 0.39 (0.84) elevations among PSE participants compared with 0.88 (1.37) among usual service participants (aIRR, 0.39; 95% CI, 0.21-0.75). However, no difference was observed among those with higher-level baseline symptoms (mean [SD] elevations, 2.06 [1.92] for PSE and 2.00 [1.91] for usual service; aIRR, 1.10; 95% CI, 0.67-1.80). Analysis of symptom scores followed the same pattern, with an adjusted mean reduction of 1.33 (95% CI, 0.36-2.29) among participants with lower-level baseline symptoms. CONCLUSIONS AND RELEVANCE: The PSE intervention is efficacious in preventing depressive symptom episodes and performs optimally among those with initial low-level symptoms. Additional effectiveness studies in Head Start are necessary to develop meaningful public health programs. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01298804.
引用
- Silverstein M, Diaz-Linhart Y, Cabral H, et al. Efficacy of a Maternal Depression Prevention Strategy in Head Start: A Randomized Clinical Trial. JAMA Psychiatry. 2017. PMID: 28614554. doi:10.1001/jamapsychiatry.2017.1001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。